Bifidobacteria found to inhibit SARS-CoV-2

Researchers have discovered certain bacteria that reside in the human intestine secrete compounds that inhibit SARS-CoV-2.   Research from Yonsei University (Seoul, South Korea), presented at the World Microbe Forum 2021 (20–24 June), has revealed commensal bacteria in the human intestine produce compounds that can inhibit SARS-CoV-2. The symptoms of COVID-19 can vary dramatically from person to person. Clinical findings have shown that some patients with moderate to severe COVID-19 display gastrointestinal symptoms, while others displayed signs of infection solely in the lungs. We previously reported on the association between COVID-19 severity and gut microbiome imbalance; now, a team led...